Cytopenias After CD19 Chimeric Antigen Receptor T-Cells (CAR-T) Therapy for Diffuse Large B-Cell Lymphomas or Transformed Follicular Lymphoma: A Single Institution ExperienceAndrew Schaefer, Basem M. William, Caner Saygin et al.|Cancer Management and Research|2021Cited by 24
Ruxolitinib Plus Nivolumab in Patients with R/R Hodgkin Lymphoma after Failure of Check-Point Inhibitors: Preliminary Report on Safety and EfficacyVeronika Bachanová, Vaishalee P. Kenkre, Livia Hegerova et al.|Blood|2021Cited by 14